玻璃体内单次注射阿柏西普后视网膜色素上皮撕裂 - Suppr

Suppr

超能文献

Retinal pigment epithelium rip following single intravitreal ziv-aflibercept injection.

作者信息

Singh Sumit Randhir, Chhablani Jay

机构信息

Smt. Kanuri Santhamma Centre for Vitreo-Retinal Diseases, L V Prasad Eye Institute, Hyderabad, Telangana, India.

出版信息

Indian J Ophthalmol. 2018 Mar;66(3):445-446. doi: 10.4103/ijo.IJO_797_17.

DOI:10.4103/ijo.IJO_797_17

PMID:29480261

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5859605/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5acb/5859605/0a284c00a1b8/IJO-66-445-g001.jpg

相似文献

Retinal pigment epithelium rip following single intravitreal ziv-aflibercept injection.玻璃体内单次注射阿柏西普后视网膜色素上皮撕裂

Indian J Ophthalmol. 2018 Mar;66(3):445-446. doi: 10.4103/ijo.IJO_797_17.

Retinal pigment epithelial tear after intravitreal aflibercept for neovascular age-related macular degeneration.玻璃体内注射阿柏西普治疗新生血管性年龄相关性黄斑变性后发生的视网膜色素上皮撕裂

Ophthalmic Surg Lasers Imaging Retina. 2015 Jan;46(1):87-90. doi: 10.3928/23258160-20150101-16.

CHOROIDAL NEOVASCULARIZATION ASSOCIATED WITH RETINAL PIGMENT EPITHELIAL TEAR IMAGED BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.脉络膜新生血管伴视网膜色素上皮撕裂的光学相干断层扫描血管造影图像。

Retin Cases Brief Rep. 2020 Fall;14(4):386-389. doi: 10.1097/ICB.0000000000000721.

SHORT-TERM SAFETY PROFILE OF INTRAVITREAL ZIV-AFLIBERCEPT.玻璃体内注射阿柏西普的短期安全性概况

Retina. 2016 Jun;36(6):1126-31. doi: 10.1097/IAE.0000000000000913.

RETINAL PIGMENT EPITHELIAL TEAR AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION: Clinical Course and Long-Term Prognosis.视网膜色素上皮撕裂与抗血管内皮生长因子疗法治疗渗出性年龄相关性黄斑变性：临床病程与长期预后

Retina. 2016 May;36(5):868-74. doi: 10.1097/IAE.0000000000000823.

OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY CHANGES IN EARLY TYPE 3 NEOVASCULARIZATION AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT.抗血管内皮生长因子治疗后早期3型新生血管形成的光学相干断层扫描血管造影变化

Retina. 2017 Oct;37(10):1873-1879. doi: 10.1097/IAE.0000000000001447.

Mechanism of retinal pigment epithelium tear formation following intravitreal anti-vascular endothelial growth factor therapy revealed by spectral-domain optical coherence tomography.频域光相干断层扫描揭示玻璃体内抗血管内皮生长因子治疗后视网膜色素上皮撕裂的形成机制。

Am J Ophthalmol. 2013 Nov;156(5):981-988.e2. doi: 10.1016/j.ajo.2013.06.024. Epub 2013 Aug 20.

Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration: 12-Month Safety and Efficacy Outcomes.玻璃体内注射阿柏西普治疗耐药性新生血管性年龄相关性黄斑变性：12个月的安全性和疗效结果。

Ophthalmic Res. 2015;55(2):84-90. doi: 10.1159/000440886. Epub 2015 Dec 5.

Intravitreal aflibercept for refractory choroidal neovascularization secondary to angioid streaks.玻璃体内注射阿柏西普治疗血管样条纹继发的难治性脉络膜新生血管。

Eye (Lond). 2016 Jun;30(6):894-5. doi: 10.1038/eye.2016.28. Epub 2016 Mar 4.

Retinal pigment epithelial tear following intravitreal ranibizumab injections for neovascular age-related macular degeneration.玻璃体内注射雷珠单抗治疗新生血管性年龄相关性黄斑变性后视网膜色素上皮撕裂

Graefes Arch Clin Exp Ophthalmol. 2007 Aug;245(8):1225-7. doi: 10.1007/s00417-007-0536-2.

本文引用的文献

DOUBLE RETINAL PIGMENT EPITHELIUM TEARS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.新生血管性年龄相关性黄斑变性中的双视网膜色素上皮撕裂

Retina. 2016 Nov;36(11):2197-2204. doi: 10.1097/IAE.0000000000001062.

Retinal pigment epithelial tears in the era of intravitreal pharmacotherapy: risk factors, pathogenesis, prognosis and treatment (an American Ophthalmological Society thesis).玻璃体内药物治疗时代的视网膜色素上皮撕裂：危险因素、发病机制、预后及治疗（美国眼科学会论文）

Trans Am Ophthalmol Soc. 2014 Jul;112:142-59.

The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy.增殖性糖尿病视网膜病变中VEGF和CTGF的血管生成-纤维化转换

PLoS One. 2008 Jul 16;3(7):e2675. doi: 10.1371/journal.pone.0002675.

Retinal pigment epithelial tear in polypoidal choroidal vasculopathy.息肉状脉络膜血管病变中的视网膜色素上皮撕裂

Retina. 2007 Sep;27(7):832-8. doi: 10.1097/IAE.0b013e318150d864.

Tears of the retinal pigment epithelium: an old problem in a new era.视网膜色素上皮撕裂：新时代的一个老问题。

Retina. 2007 Jun;27(5):523-34. doi: 10.1097/IAE.0b013e3180a032db.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验